Revolutionary drug could be new hope for adrenal cancer patients
OSI-906 in clinical trial for adrenocortical carcinoma
September 22 2009
TGen Clinical Research Services at Scottsdale Healthcare today announced the start of a clinical trial for a drug designed to combat adrenocortical carcinoma...

For the full list of trial locations go to the NIH clinicaltrials.gov website.  Currently recruiting!